Literature DB >> 22543671

Cannabinol and cannabidiol exert opposing effects on rat feeding patterns.

Jonathan A Farrimond1, Benjamin J Whalley, Claire M Williams.   

Abstract

RATIONALE: Increased food consumption following ∆(9)-tetrahydrocannabinol-induced cannabinoid type 1 receptor agonism is well documented. However, possible non-∆(9)-tetrahydrocannabinol phytocannabinoid-induced feeding effects have yet to be fully investigated. Therefore, we have assessed the effects of the individual phytocannabinoids, cannabigerol, cannabidiol and cannabinol, upon feeding behaviors.
METHODS: Adult male rats were treated (p.o.) with cannabigerol, cannabidiol, cannabinol or cannabinol plus the CB(1)R antagonist, SR141716A. Prior to treatment, rats were satiated and food intake recorded following drug administration. Data were analyzed for hourly intake and meal microstructure.
RESULTS: Cannabinol induced a CB(1)R-mediated increase in appetitive behaviors via significant reductions in the latency to feed and increases in consummatory behaviors via increases in meal 1 size and duration. Cannabinol also significantly increased the intake during hour 1 and total chow consumed during the test. Conversely, cannabidiol significantly reduced total chow consumption over the test period. Cannabigerol administration induced no changes to feeding behavior.
CONCLUSION: This is the first time cannabinol has been shown to increase feeding. Therefore, cannabinol could, in the future, provide an alternative to the currently used and psychotropic ∆(9)-tetrahydrocannabinol-based medicines since cannabinol is currently considered to be non-psychotropic. Furthermore, cannabidiol reduced food intake in line with some existing reports, supporting the need for further mechanistic and behavioral work examining possible anti-obesity effects of cannabidiol.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22543671     DOI: 10.1007/s00213-012-2697-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  46 in total

1.  Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.

Authors:  Alessia Ligresti; Aniello Schiano Moriello; Katarzyna Starowicz; Isabel Matias; Simona Pisanti; Luciano De Petrocellis; Chiara Laezza; Giuseppe Portella; Maurizio Bifulco; Vincenzo Di Marzo
Journal:  J Pharmacol Exp Ther       Date:  2006-05-25       Impact factor: 4.030

2.  Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.

Authors:  M H Rhee; Z Vogel; J Barg; M Bayewitch; R Levy; L Hanus; A Breuer; R Mechoulam
Journal:  J Med Chem       Date:  1997-09-26       Impact factor: 7.446

3.  Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists.

Authors:  América A Scopinho; Francisco S Guimarães; Fernando M A Corrêa; Leonardo B M Resstel
Journal:  Pharmacol Biochem Behav       Date:  2011-01-14       Impact factor: 3.533

4.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Behavioral comparisons of the stereoisomers of tetrahydrocannabinols.

Authors:  B R Martin; R L Balster; R K Razdan; L S Harris; W L Dewey
Journal:  Life Sci       Date:  1981-08-10       Impact factor: 5.037

6.  Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors.

Authors:  Bogna Ignatowska-Jankowska; Maciej M Jankowski; Artur H Swiergiel
Journal:  Neurosci Lett       Date:  2010-12-21       Impact factor: 3.046

7.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

8.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Authors:  C C Felder; K E Joyce; E M Briley; J Mansouri; K Mackie; O Blond; Y Lai; A L Ma; R L Mitchell
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

9.  Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.

Authors:  M Herkenham; A B Lynn; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  J Neurosci       Date:  1991-02       Impact factor: 6.167

10.  Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.

Authors:  Gareth Pryce; Zubair Ahmed; Deborah J R Hankey; Samuel J Jackson; J Ludovic Croxford; Jennifer M Pocock; Catherine Ledent; Axel Petzold; Alan J Thompson; Gavin Giovannoni; M Louise Cuzner; David Baker
Journal:  Brain       Date:  2003-07-22       Impact factor: 13.501

View more
  14 in total

1.  Neuromolecular Mechanisms of Cannabis Action.

Authors:  Yousra Adel; Stephen P H Alexander
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.

Authors:  Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2015-10-06       Impact factor: 4.530

3.  Cannabidiol ameliorates the anxiogenic and compulsive-like behaviors induced by chronic consumption of a high-carbohydrate diet in male mice.

Authors:  Anna Paula Marçal; Nícia Soares; Laila Asth; Fabricio A Moreira; Adaliene V M Ferreira; Daniele C Aguiar
Journal:  Metab Brain Dis       Date:  2022-08-30       Impact factor: 3.655

4.  Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.

Authors:  Guo-Hua Bi; Ewa Galaj; Yi He; Zheng-Xiong Xi
Journal:  Addict Biol       Date:  2019-06-19       Impact factor: 4.093

5.  Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells.

Authors:  Xin Zhang; Yao Qin; Zhaohai Pan; Minjing Li; Xiaona Liu; Xiaoyu Chen; Guiwu Qu; Ling Zhou; Maolei Xu; Qiusheng Zheng; Defang Li
Journal:  Biomolecules       Date:  2019-07-25

6.  Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Authors:  Daniel I Brierley; Joe R Harman; Natasha Giallourou; Emma Leishman; Anna Emily Roashan; Ben A D Mellows; Heather B Bradshaw; Jonathan R Swann; Ketan Patel; Benjamin J Whalley; Claire M Williams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-29       Impact factor: 12.910

7.  Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Authors:  Daniel I Brierley; James Samuels; Marnie Duncan; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2016-08-09       Impact factor: 4.530

8.  Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans.

Authors:  Suzanne E M de Bruijn; Cees de Graaf; Renger F Witkamp; Gerry Jager
Journal:  Cannabis Cannabinoid Res       Date:  2017-06-01

9.  The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.

Authors:  Silvana Y Romero-Zerbo; María García-Fernández; Vanesa Espinosa-Jiménez; Macarena Pozo-Morales; Alejandro Escamilla-Sánchez; Lourdes Sánchez-Salido; Estrella Lara; Nadia Cobo-Vuilleumier; Alex Rafacho; Gabriel Olveira; Gemma Rojo-Martínez; Benoit R Gauthier; Isabel González-Mariscal; Francisco J Bermúdez-Silva
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

Review 10.  Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol.

Authors:  Patrycja Bielawiec; Ewa Harasim-Symbor; Adrian Chabowski
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.